Role of Aspirin in High Pulsatility Index of Uterine Artery: A Consort Study
- PMID: 30224843
- PMCID: PMC6133801
- DOI: 10.1007/s13224-017-1058-4
Role of Aspirin in High Pulsatility Index of Uterine Artery: A Consort Study
Abstract
Background: Preeclampsia is a heterogeneous disorder prevalent in 3-10% of pregnant women globally. The etiology is multifactorial. There is a initial stage of endothelial dysfunction and placental ischemia (Stage 1); this leads to maternal syndrome of hypertension, edema, and proteinuria (Stage 2). Drugs acting on immunomodulatory, anti-inflammatory, antioxidant and proresolving pathways can minimize the complications of preeclampsia. The therapeutic effect of aspirin is based on acetyl group and salicylate group. Both components have independent therapeutic effects on anti-inflammatory pathway and proresolving pathway.
Aims and objectives: This study was designed to assess the effectiveness and safety of aspirin in prevention and treatment of symptoms and complications of preeclampsia in women at high risk of preeclampsia.
Methods: This is a prospective experimental study to evaluate the effectiveness of aspirin versus placebo in the prevention of maternal syndrome of preeclampsia in women with high risk of preeclampsia (G1 = 97, G2 = 92). Patients with age ≥ 34, chronic hypertension, multiple pregnancies, gestational diabetes, and high pulsatility index of uterine artery were enrolled between 12 and 20 weeks of gestation and prescribed 75 mg aspirin daily till 34 weeks of gestation. Control group was not prescribed aspirin.
Observations and results: There was a reduction in relative risk of preeclampsia in aspirin group as compared with control group. There was no significant increase in the number of cases of abruption placenta, preterm delivery, neonatal intraventricular hemorrhage, patent ductus arteriosus, and postpartum hemorrhage following aspirin therapy.
Conclusion: In patients with high mean pulsatility index of uterine arteries, low dose aspirin can be a useful intervention. Uterine artery Doppler is a simple and noninvasive test which can be used safely for the prediction of preeclampsia. Aspirin is safe, economical, and easily available commercially.
Keywords: Acetylsalicylic acid; Doppler; Preeclampsia; Ultrasound; Uterine artery.
Conflict of interest statement
The authors declare that there is no conflict of interest. We do not have any commercial association that might pose a conflict of interest in connection with the manuscript. We certify that neither this manuscript nor one with substantially similar content under our authorship has been published or is being considered for publication elsewhere.Ethical Committee approval was obtained from the Institutional Research Board.The research participants were informed about the study in local language and informed written consent was taken after explaining the nature of ultrasound Doppler scan in pregnancy. We have obtained the patient’s consent for participation in research. Ethical committee clearance and research board clearance was obtained for this study according to the Principle of Helsinki.
Figures
Similar articles
-
Two-stage screening for preterm preeclampsia at 11-13 weeks' gestation.Am J Obstet Gynecol. 2019 Feb;220(2):197.e1-197.e11. doi: 10.1016/j.ajog.2018.10.092. Epub 2018 Nov 7. Am J Obstet Gynecol. 2019. PMID: 30414394
-
Prevention of preeclampsia with aspirin.Am J Obstet Gynecol. 2022 Feb;226(2S):S1108-S1119. doi: 10.1016/j.ajog.2020.08.045. Epub 2020 Aug 21. Am J Obstet Gynecol. 2022. PMID: 32835720 Review.
-
Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial.Croat Med J. 2005 Oct;46(5):826-31. Croat Med J. 2005. PMID: 16158479 Clinical Trial.
-
Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia.Am J Obstet Gynecol. 2017 Dec;217(6):685.e1-685.e5. doi: 10.1016/j.ajog.2017.08.110. Epub 2017 Sep 6. Am J Obstet Gynecol. 2017. PMID: 28888591
-
First trimester preeclampsia screening and prediction.Am J Obstet Gynecol. 2022 Feb;226(2S):S1071-S1097.e2. doi: 10.1016/j.ajog.2020.07.020. Epub 2020 Jul 16. Am J Obstet Gynecol. 2022. PMID: 32682859 Review.
Cited by
-
Antiplatelet agents for preventing pre-eclampsia and its complications.Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD004659. doi: 10.1002/14651858.CD004659.pub3. Cochrane Database Syst Rev. 2019. PMID: 31684684 Free PMC article.
-
Could Aspirin Treatment Modify the Assessment of the Uterine Arteries?Rev Bras Ginecol Obstet. 2022 Mar;44(3):231-237. doi: 10.1055/s-0042-1742411. Epub 2022 Feb 9. Rev Bras Ginecol Obstet. 2022. PMID: 35139575 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources